West Pharmaceutical Services Inc
WST· NYSE
Released Feb 16, 2023, before the open
10-K filed Feb 21, 2023, 52 days after period end · 0000105770-23-000012
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020 | Q4 2019 |
|---|---|---|---|---|
| Revenue | $708.70M | $730.80M | $580.20M | $470.60M |
| Net Income | $103.00M | $147.70M | $98.40M |
West Pharmaceutical Services Inc · CIK 105770 · Engraved from SEC EDGAR
| $63.90M |
| EPS Diluted | — | — | $1.29 | $0.84 |
|---|
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.